Featured News
645Wire StoriesRenesas Announces Determination of Number of New Shares to be Issued and Number of Shares to be Sold
TOKYO–(BUSINESS WIRE)–Renesas Electronics Corporation (“Renesas”, TSE: 6723) today announced that, with respect to the issuance of new shares and the secondary offering...
- 913Wire Stories
Oclean X Pro Elite Ushers in Era of Deep Smart Electric Toothbrush in 2021
SHENZHEN, China–(BUSINESS WIRE)–#BlindZoneDetection–Oclean recently released Oclean X Pro Elite, the world’s very first touch screen electric toothbrush. In addition to efficient cleaning,...
- 651Wire Stories
Growing Influence of Social Media Driving China Online Content Communities Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Online Content Communities Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)” report has been added to ResearchAndMarkets.com’s...
- 612Wire Stories
China Mobile Games Report 2021: Monthly Average Revenue Per User (ARPU) and Monthly Average Revenue Per Paying User (ARPPU) Rose in 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Mobile Games 2021” report has been added to ResearchAndMarkets.com’s offering. China is worth more than 25% of the world’s...
- 686Wire Stories
Infogain Announces Ownership Transition From ChrysCapital to the Apax Funds
The Apax Fund’s investment will accelerate Infogain’s expansion LOS GATOS, Calif.–(BUSINESS WIRE)–#digitaltransformation–Infogain, a Silicon Valley-based leader in human-centered digital platform and software...
- 709Wire Stories
Invesco Office J-REIT, Inc.: Notice concerning Receiving of Revised Proposal Letter regarding Tender Offer by IRE (Cayman) Limited
TOKYO–(BUSINESS WIRE)–Invesco Office J-REIT, Inc. hereby disclosed following documents. For the details, please visit our website. Notice concerning Receiving of Revised Proposal...
- 801Wire Stories
BeiGene Presents ALPINE Results at EHA2021 Demonstrating Both Efficacy and Safety Advantages of BRUKINSA® (Zanubrutinib) in Head-to-Head Comparison to Ibrutinib in Chronic Lymphocytic Leukemia
The Phase 3 ALPINE trial met the primary endpoint at interim analysis, with BRUKINSA showing superiority in investigator-assessed overall response rate versus...
- 690Wire Stories
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure
TOKYO–(BUSINESS WIRE)–#MedTechcategory—Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it has raised 4 Billion-yen (approx. $37...
- 797Wire Stories
BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA® (Zanubrutinib) and Tislelizumab at EHA2021
BRUKINSA demonstrated long-term clinical benefits and tolerability in patients with mantle cell lymphoma and chronic lymphocytic leukemia at extended follow-up of nearly...
- 668Wire Stories
Toyoda Gosei to Launch UVC Personal Space Disinfector and Deodorizer
KIYOSU, Japan–(BUSINESS WIRE)–Toyoda Gosei Co., Ltd. (TOKYO:7282) will begin selling a “UVC Personal Space Disinfector and Deodorizer,” which uses deep ultraviolet (UVC)...
- 613News
Asian Productivity Organization (APO) Puts Productivity in the Spotlight
TOKYO, JAPAN – Media OutReach – 11 June 2021 – The Tokyo-based Asian Productivity Organization (APO) in partnership with the Japan Productivity...
